Genomic Valley Biotech Ltd — Quarterly Results & Earnings

₹28.00

+3.74%

Profit Growth YoY-100.00%Latest quarter

Sales Growth YoY-57.14%Latest quarter

Sales CAGR 5Y-0.24%5 year compound

Profit CAGR 5Y4.42%5 year compound

📋

Quarterly Performance

YoY Profit Growth-100.00%

🔴 Significant decline

YoY Sales Growth-57.14%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

20.70%

EPS Growth 5Y

4.42%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

9.68%

ROCE

11.83%

💡

Growth Analysis

Genomic Valley Biotech Ltd reported YoY profit growth of -100.00% and revenue growth of -57.14% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -0.24% and profits at 4.42% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Genomic Valley Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Biotechnology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.